Express News | Xencor Inc : Raymond James Adds Stock to Its Analyst Current Favorites List
All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy
Xencor Initiated at Overweight by Wells Fargo
Wells Fargo Initiates Xencor(XNCR.US) With Buy Rating, Announces Target Price $37
Promising Prospects for Xencor's Plamotamab in Autoimmune Treatments Drive Buy Rating
Piper Sandler Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $30
Xencor's (NASDAQ:XNCR) Growing Losses Don't Faze Investors as the Stock Rallies 5.1% This Past Week
Xencor Analyst Ratings
Piper Sandler Upgrades Xencor(XNCR.US) to Buy Rating, Raises Target Price to $30
Express News | Xencor Inc : Piper Sandler Raises Target Price to $30 From $20
Express News | Xencor Inc : Piper Sandler Raises to Overweight From Neutral
Xencor to Participate at Upcoming Investor Conferences
Xencor Reports Q3 2024 Earnings and Program Updates
Top Premarket Gainers
Xencor Insider Sold Shares Worth $1,612,639, According to a Recent SEC Filing
Barclays Maintains Xencor(XNCR.US) With Sell Rating, Maintains Target Price $22
A Quick Look at Today's Ratings for Xencor(XNCR.US), With a Forecast Between $22 to $34
Barclays Sticks to Its Sell Rating for Xencor (XNCR)
JP Morgan Maintains Overweight on Xencor, Raises Price Target to $28
Xencor, Inc.'s (NASDAQ:XNCR) Intrinsic Value Is Potentially 25% Below Its Share Price